Global Medical Partnerships
Our clinical superiority is not a claim — it is a legal and scientific fact, backed by exclusive technology transfers from the world's most advanced medical institutions. Each partner contributes a critical piece of the human body puzzle.
Full Partner Profiles
Seven exclusive technology transfer agreements — each with legal, clinical, and commercial integration.
CureSpec & Medispec
🇮🇱 IsraelTechnology
Advanced Neovascularization — stimulation of new blood vessel growth for chronic kidney disease treatment.
Clinical Impact
Provides a regenerative, non-dialysis pathway for CKD patients. Exclusive Indian commercialization rights held by Anjaniputra.
RGCC International
🇨🇭 SwitzerlandTechnology
Precision Oncology & Advanced Cancer Biology — advanced testing designed to investigate different biological and molecular characteristics of cancer, including approaches involving circulating tumour cells, molecular analysis and functional assessment. It provides additional biological information that may complement conventional cancer assessment.
Clinical Impact
Targets cancer at the cellular level. Addresses India's estimated $1 trillion oncology market. International Conference partnership active.
Aroa Biosurgery
🇳🇿 New ZealandTechnology
Bio-regenerative medicine — advanced tissue repair and medical device patches using extracellular matrix technology.
Clinical Impact
Accelerates chronic wound healing, reduces hospitalization duration, and prevents recurrence through biological scaffolding.
European Biomedical Group
🇩🇪 GermanyTechnology
Bio-regenerative medicine — restoration of metabolic and biological functions through a network of 16 specialist sister companies.
Clinical Impact
Cell therapy, organ repair, and metabolic restoration protocols. Foundation partner of the Regenerative Cell network.
NHS UK
🇬🇧 United KingdomTechnology
Quantum nanoparticles for targeted oncology + advanced blood-bag technology for fluid management in cancer care.
Clinical Impact
Cutting-edge nanotechnology for precision cancer treatment — currently absent from all major Indian hospital competitors.
NaviPoint Health
🇺🇸 USATechnology
Microbiome science — gut restore, rehabilitation, and re-balance protocols backed by scientific discovery.
Clinical Impact
Personalised health insights for adults, children, and longevity patients. Gut-immune-brain axis restoration.
SRAM MRAM Group
🌐 UK / GlobalTechnology
Strategic investment, global hospital infrastructure, and high-level corporate medical partnerships.
Clinical Impact
High-level strategic and financial partnership for global expansion.
Bringing the Information Into Practice
Advanced technology requires both professional education and meaningful interpretation.
For Clinicians
Dr Ravi Tej Allam, MD
Precision Oncology Education & Practitioner Development
Supporting clinician education, practitioner development and understanding of RGCC technologies through masterclasses, educational programmes and case-based learning.
Learn about RGCC Practitioner Education →For Patients
Dr Jervin Lim, DMin
Precision Oncology & Cancer Strategy
Helping patients understand and connect advanced cancer-testing information — including RGCC reports — with pathology, imaging, treatment history, cancer biology and metabolic factors.
Explore Cancer Strategy →Domestic Research Infrastructure
World-class international science, domesticated through India's premier research institutions.
IIT Hyderabad
Research Incubator
Technology development, R&D support, and local academic synergy for the domestication of international medical science.
CCMB Hyderabad
Centre for Cellular & Molecular Biology
Molecular platform partner for regulatory-grade research and Indian clinical validation of global protocols.
C-CAMP Bangalore
Centre for Cellular & Molecular Platforms
Biotech incubation and regulatory research support. Key partner for CDSCO compliance and technology commercialization.
🌐 ccamp.res.in
Medispec India
Clinical Diagnostics
Precision diagnostic capabilities integrated into the Anjaniputra technology matrix.
🌐 medispec.in
CDSCO
Central Drugs Standard Control Organisation
National regulatory body for all medical device and drug approvals. Anjaniputra maintains proactive alignment with CDSCO for smooth technology adoption.
Whether you are seeking answers for a chronic condition or exploring regenerative medicine — we have a pathway for you.
Our care team is ready to match you with the right specialist and the world's most advanced treatment protocol.